Cite
MLA Citation
Amira Barkal et al.. “Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.” Nature immunology, vol. 19, 2018, pp. 76–84. http://access.bl.uk/ark:/81055/vdc_100088107944.0x00016b